Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

photo not available

Contact

210-567-8355

saklad@uthscsa.edu

Departments & Divisions

Stephen R Saklad

  • Professional Background

    Education

    • 1979 - Clinical Fellowship - Psychiatric Pharmacy - University of Nebraska Medical Center, Nebraska Psychiatric Institute
    • 1978 - PharmD - Pharmacy - University of Southern California, School of Pharmacy
    • 1974 - BA - Bacteriology (Cum Laude) - University of California at Los Angeles, Department of Bacteriology

    Appointments

    • 9/2010 - Adjoint Associate Professor - UT Health Science Center San Antonio, Medicine, San Antonio
    • 1/2010 - Clinical Pharmacologist - San Antonio State Hospital, Houston Hall, Residential Care Unit, Pharmacy, San Antonio
    • 7/1996 - Clinical Pharmacologist - San Antonio State Hospital, Adolescent UnitSan Antonio
    • 9/1985 - Clinical Associate Professor - University of Texas at Austin College of Pharmacy, Pharmacotherapy, Austin
    • 9/1979 - Clinical Psychopharmacology Consultant - San Antonio State HospitalSan Antonio

  • Instruction & Training

    • - Present, Individual Instruction, San Antonio State Hospital
    • - Present, Psychiatric Pharmacy Journal Club, The University of Texas Health Science Center, STVHCS, San Antonio State Hospital
    • - Present, PHR 296P Advanced Pharmacotherapy Lab
    • - Present, PHR 283L Clinical Skills Laboratory course
    • - Present, PHR 238S Toxicology Module
    • - Present, PHR 189F Neurology Pharmacotherapeutics Module
    • - Present, PHR W385E Pharmacotherapy of CNS Disorders
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • - Present, PHR W593C Acute Care Pharmacy Practicum
    • - Present, PHR 488U Psychiatric Pathophysiology and Pharmacotherapeutics Modules
    • - Present, PHR 396F Advanced Pharmacotherapy Course
    • - Present, PHR 396F Advanced Pharmacotherapy Course
    • - Present, Individual Instruction, University of Texas College of Pharmacy
    • 1/1998 - Present, Rotation Student Supervision, UTHSCSA Department of Psychiatry
    • 1/1990 - Present, Bipolar Disoder Pharmacotherapeutics

  • Research & Grants

    Grants

    Private

    Funding Agency Title Retrospective Review of Carnitine Therapy in Developmentally Disabled Individuals on Valproic Acid Status Complete Period - Present Role Co-Principal Investigator Grant Detail Funding Agency Title Psychogenic Polydipsia and Treatment of Cevimeline Status Active Period - Present Role Principal Investigator Grant Detail Investigator Initiated Protocol in Development Funding Agency Title A Phase 3, Randomized, Active Comparator-controller Clinical Trial to Assess the Long-Term Safety and Efficacy of SM-13496/Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Status Active Period - Present Role Principal Investigator Grant Detail

     

    Funding Agency Title A Randomized, Double-blind, Placebo-controlled and Olanzapine-referenced, Parallel-group Safety and Efficacy Study of Two Fixed Doses of Bifeprunox in the Treatment of Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mgeq., 100 mg eq., and 150 mg ep.) of Paliperidone Palmitate in Subjects With Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Randomized, Crossover Study to Evaluate the Overall Safety and Tolerability of Paliperidone Palmatate Injected in the Deltoid or Gluteus Muscle in Subjects With Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group, Fixed Dose Study of the Effect of Bifeprunox Versus Olanzapine in the Treatment of Outpatients with Schizophrenia - Extension Phase Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group, Fixed Dose Study of the Effect of Bifeprunox versus Olanzapine in the Treatment of Outpatients with Schizophrenia - Extension Phase Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group Fixed-dose Study of the Effect of Weight of Bifeprunox Versus Olanzapine in the Treatment of Outpatients with Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail Funding Agency Title A Multicenter, Randomized, Double-blind, Parallel-group, Fixed Dose Study of the Effect of Bifeprunox Versus Olanzapine in the Treatment of Outpatients with Schizophrenia Status Complete Period - Present Role Co-Investigator Grant Detail